MARIE ANDERSON: Open Payments
NPI 1013916774 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 38 payments from 16 companies in 2025. Trend: 2023 $1,016 · 2024 $1,369 · 2025 $1,150
Food & beverage: $1,065Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $351 |
| Ferring Pharmaceuticals Inc. | 7 | $188 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $157 |
| Endo USA, Inc. | 4 | $88 |
| Astellas Pharma US Inc | 3 | $76 |
| Boston Scientific Corporation | 2 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Tempus AI, Inc | 1 | $27 |
| Teleflex LLC | 1 | $24 |
Products named: ERLEADA, ADSTILADRIN, Nubeqa, RYBREVANT, XIAFLEX, Xtandi, ORGOVYX, PROVENGE.
Industry payments across GA — which companies pay providers there.
